Mitomycin intravesical - Situs
Alternative Names: I-MMCLatest Information Update: 25 Dec 2021
At a glance
- Originator Situs Corporation
- Class Amines; Antiglaucomas; Antineoplastics; Aza compounds; Aziridines; Carbamates; Cytostatic antibiotics; Eye disorder therapies; Heterocyclic compounds with 4 or more rings; Indoles; Mitomycins; Pyrroles; Small molecules
- Mechanism of Action DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bladder cancer
Most Recent Events
- 08 May 2001 I-MMC is available for licensing
- 08 May 2001 New profile
- 08 May 2001 Phase-III clinical trials for Bladder cancer in USA (Intravesicular)